SHVARTS, G. Y. Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis. Ukrainian Neurosurgical Journal, [S. l.], n. 2, p. 85–91, 2005. DOI: 10.25305/unj.132316. Disponível em: https://theunj.org/article/view/132316. Acesso em: 29 nov. 2024.